HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Platelet activation independent of pulmonary inflammation contributes to diesel exhaust particulate-induced promotion of arterial thrombosis.

AbstractBACKGROUND:
Accelerated thrombus formation induced by exposure to combustion-derived air pollution has been linked to alterations in endogenous fibrinolysis and platelet activation in response to pulmonary and systemic inflammation. We hypothesised that mechanisms independent of inflammation contribute to accelerated thrombus formation following exposure to diesel exhaust particles (DEP).
METHODS:
Thrombosis in rats was assessed 2, 6 and 24 h after administration of DEP, carbon black (CB; control carbon nanoparticle), DQ12 quartz microparticles (to induce pulmonary inflammation) or saline (vehicle) by either intra-tracheal instillation (0.5 mg, except Quartz; 0.125 mg) or intravenous injection (0.5 mg/kg). Thrombogenicity was assessed by carotid artery occlusion, fibrinolytic variables and platelet-monocyte aggregates. Measures of inflammation were determined in plasma and bronchoalveolar lavage fluid. Tissue plasminogen activator (t-PA) and plasminogen activator inhibitor (PAI)-1 were measured following direct in vitro exposure of human umbilical vein endothelial cells (HUVECs) to DEP (10-150 μg/mL).
RESULTS:
Instillation of DEP reduced the time to thrombotic occlusion in vivo, coinciding with the peak of DEP-induced pulmonary inflammation (6 h). CB and DQ12 produced greater inflammation than DEP but did not alter time to thrombotic occlusion. Intravenous DEP produced an earlier (2 h) acceleration of thrombosis (as did CB) without pulmonary or systemic inflammation. DEP inhibited t-PA and PAI-1 release from HUVECs, and reduced the t-PA/PAI-1 ratio in vivo; similar effects in vivo were seen with CB and DQ12. DEP, but not CB or DQ12, increased platelet-monocyte aggregates.
CONCLUSION:
DEP accelerates arterial thrombus formation through increased platelet activation. This effect is dissociated from pulmonary and systemic inflammation and from impaired fibrinolytic function.
AuthorsCaroline M Tabor, Catherine A Shaw, Sarah Robertson, Mark R Miller, Rodger Duffin, Ken Donaldson, David E Newby, Patrick W F Hadoke
JournalParticle and fibre toxicology (Part Fibre Toxicol) Vol. 13 Pg. 6 (Feb 09 2016) ISSN: 1743-8977 [Electronic] England
PMID26857113 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
Chemical References
  • Inflammation Mediators
  • Plasminogen Activator Inhibitor 1
  • SERPINE1 protein, human
  • Soot
  • Vehicle Emissions
  • Quartz
  • Tissue Plasminogen Activator
Topics
  • Animals
  • Arterial Occlusive Diseases (blood, chemically induced)
  • Blood Platelets (drug effects, metabolism)
  • Bronchoalveolar Lavage Fluid (chemistry)
  • Carotid Stenosis (blood, chemically induced)
  • Cells, Cultured
  • Fibrinolysis (drug effects)
  • Human Umbilical Vein Endothelial Cells (drug effects, metabolism)
  • Inflammation Mediators (blood)
  • Male
  • Particle Size
  • Plasminogen Activator Inhibitor 1 (metabolism)
  • Platelet Activation
  • Platelet Adhesiveness (drug effects)
  • Pneumonia (blood, chemically induced)
  • Quartz (toxicity)
  • Rats, Wistar
  • Soot (toxicity)
  • Thrombosis (blood, chemically induced)
  • Time Factors
  • Tissue Plasminogen Activator (metabolism)
  • Vehicle Emissions (toxicity)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: